Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Green

Showing results (361-370 of 433) with videos related to

Pageof 44
Sort By:
Alcoholism, Clinical and Experimental Research|April 29, 2004
Pharmacological treatment of alcohol abuse/dependence with psychiatric comorbidityCharlene E Le Fauve, Raye Z Litten, Carrie L Randall, et al.
Plos One|October 20, 2012
Ancient Ephemeroptera-Collembola symbiosis fossilized in amber predicts contemporary phoretic associationsDavid Penney, Andrew McNeil, David I Green, et al.
The Journal of Clinical Psychiatry|September 15, 2007
Longer time to antipsychotic treatment discontinuation for any cause is associated with better functional outcomes for patients with schizophrenia, schizophreniform disorder, or schizoaffective disorderEduardo Dunayevich, Haya Ascher-Svanum, Fangyi Zhao, et al.
Dalton Transactions (Cambridge, England : 2003)|September 26, 2017
(C^N<sup>pz</sup>^C)Au<sup>III</sup> complexes of acyclic carbene ligands: synthesis and anticancer propertiesMorwen Williams, Adam I Green, Julio Fernandez-Cestau, et al.
Protein Expression and Purification|March 1, 1996
High level expression of human MCP-1 using the LCR/MEL expression systemM Needham, D Barratt, G Cerillo, et al.
Psychiatry Research|July 26, 2002
Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorderCarla M Canuso, Jill M Goldstein, Joanne Wojcik, et al.
Schizophrenia Research|April 6, 2004
First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidolAlan I Green, Mauricio F Tohen, Robert M Hamer, et al.
Infection and Immunity|June 3, 2015
Murine model of chemotherapy-induced extraintestinal pathogenic Escherichia coli translocationSabrina I Green, Nadim J Ajami, Li Ma, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 3, 2002
Effects of risperidone on the peripheral noradrenegic system in patients with schizophrenia: a comparison with clozapine and placeboIgor Elman, David S Goldstein, Alan I Green, et al.
European Journal of Immunology|March 1, 1985
Abnormalities in autologous mixed lymphocyte reaction-activated immunologic processes in systemic lupus erythematosus and their possible correction by interleukin 2S Takada, Y Ueda, N Suzuki, et al.
Pageof 44

Showing results (361-370 of 433) with videos related to

Sort By:
Pageof 44
Alcoholism, Clinical and Experimental Research|April 29, 2004
Pharmacological treatment of alcohol abuse/dependence with psychiatric comorbidityCharlene E Le Fauve, Raye Z Litten, Carrie L Randall, et al.
Plos One|October 20, 2012
Ancient Ephemeroptera-Collembola symbiosis fossilized in amber predicts contemporary phoretic associationsDavid Penney, Andrew McNeil, David I Green, et al.
The Journal of Clinical Psychiatry|September 15, 2007
Longer time to antipsychotic treatment discontinuation for any cause is associated with better functional outcomes for patients with schizophrenia, schizophreniform disorder, or schizoaffective disorderEduardo Dunayevich, Haya Ascher-Svanum, Fangyi Zhao, et al.
Dalton Transactions (Cambridge, England : 2003)|September 26, 2017
(C^N<sup>pz</sup>^C)Au<sup>III</sup> complexes of acyclic carbene ligands: synthesis and anticancer propertiesMorwen Williams, Adam I Green, Julio Fernandez-Cestau, et al.
Protein Expression and Purification|March 1, 1996
High level expression of human MCP-1 using the LCR/MEL expression systemM Needham, D Barratt, G Cerillo, et al.
Psychiatry Research|July 26, 2002
Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorderCarla M Canuso, Jill M Goldstein, Joanne Wojcik, et al.
Schizophrenia Research|April 6, 2004
First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidolAlan I Green, Mauricio F Tohen, Robert M Hamer, et al.
Infection and Immunity|June 3, 2015
Murine model of chemotherapy-induced extraintestinal pathogenic Escherichia coli translocationSabrina I Green, Nadim J Ajami, Li Ma, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 3, 2002
Effects of risperidone on the peripheral noradrenegic system in patients with schizophrenia: a comparison with clozapine and placeboIgor Elman, David S Goldstein, Alan I Green, et al.
European Journal of Immunology|March 1, 1985
Abnormalities in autologous mixed lymphocyte reaction-activated immunologic processes in systemic lupus erythematosus and their possible correction by interleukin 2S Takada, Y Ueda, N Suzuki, et al.
Pageof 44